Discrepancies revealed in GP referral letters
A comparison of medicines information contained in GP referral letters with that elicited from Home Medicines Reviews (HMRs) has found discrepancies for 90% of...
Pharmacists in 2023 – unlocking the future of pharmacy
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...
Record number of COVID-19 vaccines administered
Hundreds of Victorians are on alert after potential exposure to the virus, as more Australians line up to receive the vaccine.
New Parliamentary Friendship Group champions safer medicines use
The PSA has supported the launch of the inaugural Parliamentary Friends of Safe and Quality Use of Medicines event, using the opportunity to call...
Pharmacists in 2023: roles and remuneration
Better remuneration and career support are key to the future of pharmacists’ roles.
The pharmacy profession provides a much broader range of health services...
Lack of evidence raises questions on long-term PPI use
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...
